Abiomed reported $224.52M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6324M 584M
Abiomed ABMD:US $ 224.52M 6.13M
Atricure ATRC:US $ 63.52M 7.92M
Baxter International BAX:US $ 1457M 107M
Boston Scientific BSX:US $ 2222M 163M
Cantel Medical CMN:US $ 144.21M 4.46M
Cardiovascular Systems CSII:US $ 46.23M 4.8M
Cooper Companies COO:US $ 532.5M 14.1M
Dexcom DXCM:US $ 449.5M 51.4M
Edwards Lifesciences EW:US $ 1104.5M 62.6M
Getinge GETIB:SS 3.15B 96M
Globus Medical GMED:US $ 195.18M 23.8M
Hologic HOLX:US $ 559M 387.6M
Inogen INGN:US $ 46.26M 11.25M
Insulet PODD:US $ 190.3M 19.4M
Integra Lifesciences IART:US $ 254.54M 15.94M
Johnson & Johnson JNJ:US $ 16101M 273M
Masimo MASI:US $ 258.2M 53.44M
Medtronic MDT:US $ 5524M 194M
Merit Medical Systems MMSI:US $ 135.07M 14.16M
Nuvasive NUVA:US $ 224.69M 13.03M
Stryker SYK:US $ 2843M 116M
Tandem Diabetes Care TNDM:US $ 101.95M 10.85M
Teleflex TFX:US $ 388.83M 42.6M
Terumo 4543:JP Y 101638M 11138M
Zimmer Biomet Holdings Inc ZBH:US $ 1.27B 107.6M